Oral treatment of helicobacter infection
US5538729A · kind A · utility
35Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 1994 |
| Grant date | Jul 23, 1996 |
| Priority date | — |
| Expiry date | Aug 22, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55544
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of eliciting in a mammalian host a protective immune response to Helicobacter infection, by orally administering to the host an immunogenically effective amount of Helicobacter antigen. Vaccine compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.